An opioid antagonist medication used to facilitate maintenance of abstinence after heroin or alcohol detoxification. Marketed under the brand names revia and vivitrol; may also be known by the discontinued brand name depade.
A narcotic antagonist.
Oral agent that antagonizes the actions of opiates, used to aid former drug addicts in remaining opiate-free in their day-to-day activities. It should not be used without a physician’s directions.
A drug that is an antagonist to narcotic substances. Given orally, it is used in the maintenance treatment of heroin and other opiate-dependent people.
An opioid antagonist used to treat addiction to narcotics and alcohol.
A pharmaceutical compound initially formulated to address heroin or morphine addiction, which is also employed in the treatment of alcoholism. Its mechanism of action involves diminishing the desire for alcohol instead of inducing vomiting or other unfavorable responses.
Naltrexone is an opioid antagonist, a medication designed to counteract the impacts of opioid analgesic drugs. It is employed in managing opioid addiction. Naltrexone functions by obstructing the effects of opioid drugs and inducing withdrawal symptoms in individuals dependent on opioids. This treatment approach can be applied to individuals who were previously addicted to opioids to assist in averting relapse.